protoporphyrin ix has been researched along with methyl 5-aminolevulinate in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (19.57) | 29.6817 |
2010's | 34 (73.91) | 24.3611 |
2020's | 3 (6.52) | 2.80 |
Authors | Studies |
---|---|
Callan, JF; Jack, IG; Kavanagh, ON; Loan, P; McEwan, C; McHale, AP; McKenna, K; Nesbitt, H; Nicholas, D | 1 |
Iani, V; Juzenas, P; Juzeniene, A; Ma, LW; Moan, J | 1 |
Hong, SH; Kwon, YH; Lee, JB; Lee, SC; Won, Y; Yu, HY; Yun, SJ | 1 |
Campbell, S; Curnow, A; Pye, A | 1 |
Haedersdal, M; Togsverd-Bo, K; Wiegell, SR; Wulf, HC | 1 |
Enk, CD; Eriksen, P; Haedersdal, M; Philipsen, PA; Wiegell, SR; Wulf, HC | 1 |
de Bruijn, HS; Meijers, C; Robinson, DJ; Sterenborg, HJ; van der Ploeg-van den Heuvel, A | 1 |
Cicarma, E; Juzeniene, A; Ma, LW; Moan, J; Tuorkey, M | 1 |
Ferguson, J; Lesar, A; Moseley, H | 2 |
Bloznelyte-Plesniene, L; Liutkeviciūte-Navickiene, J; Mordas, A; Simkute, S | 1 |
Campbell, S; Curnow, A; Tyrrell, J | 1 |
Denk, K; Enk, A; Gholam, P; Hartmann, M; Sehr, T | 1 |
Campbell, SM; Curnow, A; Tyrrell, J | 1 |
Carrasco, E; Cogno, IS; Gilaberte, Y; Juarranz, A; Milla, LN; Rivarola, VA; Rodríguez, ME; Sanz-Rodríguez, F; Zamarrón, A | 1 |
Campbell, SM; Curnow, A; Morton, C; Tyrrell, JS | 1 |
Allan, D; Allan, E; Bayat, A; Colthurst, J; Sebastian, A | 1 |
Blázquez-Castro, A; Calvo, MI; Carrasco, E; Espada, J; Jaén, P; Juarranz, A; Sánz-Rodríguez, F; Stockert, JC | 1 |
Haedersdal, M; Lerche, CM; Philipsen, PA; Poulsen, T; Togsverd-Bo, K; Wulf, HC | 1 |
Baldursson, BT; Bäumler, W; Enk, CD; Fabricius, S; Heydenreich, J; Rosso, S; Wiegell, SR; Wulf, HC | 1 |
Allan, D; Allan, E; Alonso-Rasgado, T; Bayat, A; Mandal, P; Mendoza, J; Sebastian, A | 1 |
Hædersdal, M; Idorn, LW; Philipsen, PA; Togsverd-Bo, K; Wulf, HC | 1 |
Allen, J; Blake, E; Curnow, A; Shore, A; Thorn, C | 1 |
Allen, J; Blake, E; Campbell, S; Curnow, A; Helliwell, P; Mathew, J | 1 |
Barge, J; Kasraee, B; Piffaretti, F; Salomon, D; van den Bergh, H; Wagnières, G; Zellweger, M | 1 |
Petersen, B; Wiegell, SR; Wulf, HC | 2 |
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K; Wulf, HC | 1 |
Fabricius, S; Lerche, CM; Philipsen, PA; Wulf, HC | 1 |
Nissen, CV; Philipsen, PA; Wulf, HC | 1 |
Ibbotson, SH; Kulyk, O; Moseley, H; Samuel, ID; Valentine, RM | 1 |
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
Nissen, CV; Philipsen, PA; Wiegell, SR; Wulf, HC | 1 |
Christiansen, K; Erlendsson, AM; Haak, CS; Haedersdal, M; Taudorf, EH; Thaysen-Petersen, D; Wulf, HC | 1 |
Curnow, A; Dodd, NJF; Dogra, Y; Ferguson, DCJ; Smerdon, GR; Winyard, PG | 1 |
Heerfordt, IM; Mikkelsen, CS; Nissen, CV; Wiegell, SR; Wulf, HC | 1 |
Bowling, J; Campbell, S; Ibbotson, S; Kownacki, S; Morton, CA; Sivaramakrishnan, M; Stones, R; Valentine, R | 1 |
Bouvier, G; Comby, P; Gaborit, A; Hanaizi, J; Kouidhi, M; Osman-Ponchet, H; Ruty, B; Sevin, K | 1 |
Bay, C; Ferrick, B; Haedersdal, M; Lerche, CM; Philipsen, PA; Togsverd-Bo, K | 1 |
Bieliauskiene, G; Heerfordt, IM; Wulf, HC | 1 |
Barlier, C; Bezdetnaya, L; Dolivet, G; Francois, A; Leufflen, L; Marchal, F; Salleron, J | 1 |
Carrasco, E; Damian, A; Delgado-Wicke, P; Juarranz, Á; Lucena, SR; Mascaraque, M | 1 |
Wulf, HC | 1 |
Bagnato, VS; Moriyama, LT; Stringasci, MD; Vollet-Filho, JD | 1 |
Brebi, P; Buchegger, K; Ili, C; Kurachi, C; León, D; Mora-Lagos, B; Riquelme, I; Roa, JC; Schafer, F; Silva, R; Viscarra, T; Zanella, L | 1 |
Bagnato, VS; Buzza, HH; Ciol, H; Inada, NM; Leite, IS; Romano, RA; Stringasci, MD | 1 |
14 trial(s) available for protoporphyrin ix and methyl 5-aminolevulinate
Article | Year |
---|---|
Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Cell Line, Tumor; Humans; In Vitro Techniques; Iron Chelating Agents; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Pyridones; Skin Neoplasms | 2008 |
Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial.
Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Edema; Erythema; Female; Fluorescence; Humans; Laser Therapy; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Diseases; Treatment Outcome | 2008 |
Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Drug; Facial Dermatoses; Female; Heliotherapy; Humans; Keratosis; Male; Middle Aged; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Single-Blind Method; Treatment Outcome | 2008 |
A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Female; Fluorescence; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Time Factors | 2009 |
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Protoporphyrins; Scalp Dermatoses; Skin Neoplasms | 2011 |
Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Oxygen; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Pressure; Protoporphyrins; Skin Neoplasms | 2013 |
The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
Topics: Aminolevulinic Acid; Biological Transport; Carcinoma, Basal Cell; Injections; Oxygen; Photosensitizing Agents; Pressure; Prodrugs; Protoporphyrins; Skin Neoplasms; Spectrometry, Fluorescence; Time Factors | 2012 |
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Clobetasol; Erythema; Facial Dermatoses; Female; Fluoroscopy; Glucocorticoids; Humans; Keratosis, Actinic; Male; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2014 |
Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Aminolevulinic Acid; Drug Combinations; Female; Fluorescence; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Young Adult | 2015 |
Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Optical Imaging; Photosensitizing Agents; Point-of-Care Systems; Protoporphyrins; Skin Neoplasms | 2015 |
Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Erythema; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2016 |
Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Drug Eruptions; Erythema; Female; Fluorescence; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Protoporphyrins | 2017 |
Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aminolevulinic Acid; Curettage; Denmark; Dermabrasion; Female; Fluorescence; Humans; Laser Therapy; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Young Adult | 2017 |
Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Scalp | 2018 |
32 other study(ies) available for protoporphyrin ix and methyl 5-aminolevulinate
Article | Year |
---|---|
Comparing the efficacy of photodynamic and sonodynamic therapy in non-melanoma and melanoma skin cancer.
Topics: Aminolevulinic Acid; Animals; Heterografts; Humans; Melanoma; Mice, SCID; Photochemotherapy; Skin Neoplasms; Ultrasonic Therapy | 2016 |
Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
Topics: Administration, Cutaneous; Adult; Aminolevulinic Acid; Humans; Middle Aged; Photosensitizing Agents; Protoporphyrins; Skin; Skin Absorption; Spectrometry, Fluorescence | 2006 |
Photodetection of basal cell carcinoma using methyl 5-aminolaevulinate-induced protoporphyrin IX based on fluorescence image analysis.
Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Male; Middle Aged; Photosensitizing Agents; Protoporphyrins; Sensitivity and Specificity; Spectrometry, Fluorescence | 2007 |
Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Mice; Microscopy, Fluorescence; Photosensitizing Agents; Protoporphyrins; Skin | 2008 |
Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells.
Topics: Aminolevulinic Acid; Calcitriol; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Tumor Stem Cell Assay | 2009 |
[Fluorescence diagnostics of skin tumors using 5-aminolevulinic acid and its methyl ester].
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chi-Square Distribution; Esters; Female; Fluorescence; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Photosensitizing Agents; Precancerous Conditions; Prognosis; Protoporphyrins; Sensitivity and Specificity; Skin; Skin Neoplasms | 2009 |
Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
Topics: Aged; Aminolevulinic Acid; Dose-Response Relationship, Drug; Fluorescence; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reproducibility of Results; Skin; Skin Neoplasms | 2010 |
Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cosmetic Techniques; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Nerve Endings; Pain; Pain Measurement; Photochemotherapy; Protoporphyrins; Retrospective Studies; Sex Characteristics; Treatment Outcome | 2010 |
Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Combinations; Female; Humans; Male; Metabolic Clearance Rate; Microscopy, Fluorescence; Middle Aged; Organ Specificity; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution; Treatment Outcome | 2011 |
An investigation of the fluorescence induced by topical application of 5-aminolaevulinic acid and methyl aminolaevulinate at different body sites on normal human skin.
Topics: Administration, Cutaneous; Adult; Aminolevulinic Acid; Back; Female; Fluorescence; Forearm; Humans; Leg; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin | 2011 |
Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy.
Topics: Aminolevulinic Acid; beta Catenin; Cadherins; Carcinoma, Squamous Cell; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cell Nucleus Shape; Cell Shape; Cell Survival; Cytoskeletal Proteins; Drug Resistance, Neoplasm; Humans; Inhibitor of Apoptosis Proteins; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Neoplasms; Ubiquitin-Protein Ligases | 2011 |
Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy.
Topics: Adult; Aged; Aminolevulinic Acid; Apoptosis; Blotting, Western; Case-Control Studies; Caspase 3; Cell Proliferation; Cells, Cultured; Collagen Type I; Collagen Type III; Combined Modality Therapy; Electric Stimulation Therapy; Enzyme Activation; Female; Fibroblasts; Flow Cytometry; Gene Expression Regulation; Humans; Keloid; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinase 2; Membrane Potential, Mitochondrial; Middle Aged; Necrosis; Photochemotherapy; Photosensitizing Agents; Polymerase Chain Reaction; Protoporphyrins; Reactive Oxygen Species; Time Factors | 2011 |
Protoporphyrin IX-dependent photodynamic production of endogenous ROS stimulates cell proliferation.
Topics: Aminolevulinic Acid; Cell Cycle; Cell Proliferation; Humans; Keratinocytes; NADPH Oxidase 1; NADPH Oxidases; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Species; src-Family Kinases; Tumor Cells, Cultured | 2012 |
Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Biological Availability; Female; Humans; Mice; Mice, Hairless; Microscopy, Fluorescence; Models, Animal; Photochemotherapy; Photosensitizing Agents; Porphyrins; Precancerous Conditions; Protoporphyrins; Skin; Skin Neoplasms; Tissue Distribution; Ultraviolet Rays | 2012 |
Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
Topics: Aminolevulinic Acid; Dose-Response Relationship, Radiation; Europe; Geography, Medical; Humans; Israel; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Radiometry; Residence Characteristics; Seasons; Skin Neoplasms; Sunlight; Temperature; Ultraviolet Rays; Weather | 2013 |
Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion.
Topics: Adult; Aminolevulinic Acid; Apoptosis; Cell Differentiation; Cells, Cultured; Cellular Senescence; Female; Fibroblasts; Humans; Keloid; Male; Middle Aged; Photochemotherapy; Protoporphyrins; Reactive Oxygen Species; Skin | 2012 |
Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
Topics: Adolescent; Adult; Aminolevulinic Acid; Dermis; Epidermis; Humans; Lasers, Dye; Light; Microscopy, Fluorescence; Middle Aged; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Young Adult | 2012 |
Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy.
Topics: Aged; Aminolevulinic Acid; Fluorescence; Humans; Keratosis, Actinic; Middle Aged; Pain; Pain Measurement; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Treatment Outcome | 2013 |
Calcipotriol pretreatment enhances methyl aminolevulinate-induced protoporphyrin IX: an in vivo study in hairless mice.
Topics: Aminolevulinic Acid; Animals; Calcitriol; Dermatologic Agents; Female; Mice; Mice, Nude; Photosensitizing Agents; Protoporphyrins; Skin | 2015 |
Correlation between treatment time, photobleaching, inflammation and pain after photodynamic therapy with methyl aminolevulinate on tape-stripped skin in healthy volunteers.
Topics: Adult; Aminolevulinic Acid; Erythema; Fluorescence; Forearm; Humans; Inflammation; Male; Middle Aged; Pain; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Pigmentation; Time Factors; White People; Young Adult | 2015 |
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Short-term chemical pretreatment cannot replace curettage in photodynamic therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Curettage; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorescence; Healthy Volunteers; Humans; Keratolytic Agents; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Salicylic Acid; Young Adult | 2016 |
Ablative fractional laser enhances MAL-induced PpIX accumulation: Impact of laser channel density, incubation time and drug concentration.
Topics: Adolescent; Adult; Aminolevulinic Acid; Humans; Lasers; Male; Photosensitizing Agents; Protoporphyrins; Spectrometry, Fluorescence; Young Adult | 2016 |
The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Survival; Histidine; Humans; Iron Chelating Agents; Metalloporphyrins; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Pyridones; Reactive Oxygen Species | 2016 |
A consensus on the use of daylight photodynamic therapy in the UK.
Topics: Aminolevulinic Acid; Consensus; Humans; Keratosis, Actinic; Light; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; United Kingdom | 2017 |
Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
Topics: Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Absorption; Sunscreening Agents | 2017 |
Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Cell Line; Computer Systems; Female; Heterografts; Humans; Mice; Protoporphyrins; Spectrometry, Fluorescence; Squamous Intraepithelial Lesions of the Cervix; Tissue Distribution; Vulvar Neoplasms | 2018 |
Mitotic Catastrophe Induced in HeLa Tumor Cells by Photodynamic Therapy with Methyl-aminolevulinate.
Topics: Aminolevulinic Acid; Biomarkers; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; HeLa Cells; Humans; Microtubules; Mitosis; Photochemotherapy; Photosensitizing Agents; Protein Transport; Protoporphyrins; Spindle Apparatus | 2019 |
Daylight PDT acts by continuous activation of PpIX.
Topics: Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Sunlight; Time Factors | 2019 |
Temperature effect on the PpIX production during the use of topical precursors.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Rats; Rats, Wistar; Temperature | 2020 |
Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.
Topics: Aminolevulinic Acid; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Cell Death; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Ferrochelatase; Heat-Shock Proteins; Humans; Membrane Transport Proteins; Molecular Chaperones; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Species; Skin Neoplasms; Stress, Physiological; Superoxide Dismutase; Survivin; Symporters | 2020 |
MAL-associated methyl nicotinate for topical PDT improvement.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Cell Line; Cell Survival; Humans; Male; NAD; Nicotinic Acids; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Rats, Wistar; Skin; Skin Diseases | 2020 |